HomeMedicines › Montair FX Tablet

Montair FX Tablet

Montelukast (10mg)

MRP (typical)
₹283.73 – ₹383.87
GST rate
5.0%
HSN
3004
Schedule
General
Pack
strip of 15 tablets
Manufacturer
Cipla Ltd

About Montair FX Tablet

Montair FX Tablet contains Montelukast 10mg, which belongs to the class of leukotriene receptor antagonists. This prescription medication is classified under Schedule H and is commonly available in 10mg tablet strength. The medicine is subject to 5% GST under HSN code 3004 in India. It is typically dispensed in strip packaging containing 15 tablets and requires a valid prescription from a registered medical practitioner for purchase.

Substitutes and alternatives

The following medicines contain the same active ingredient (Montelukast (10mg)) and may be offered by pharmacists as substitutes. Actual substitute selection depends on availability at your pharmacy and prescribing doctor's instructions.

Montair 10 Tablet
MRP ₹318.42
Allegra-M Tablet
MRP ₹241.48
Montair-LC Tablet
MRP ₹336.0

Frequently asked

What is the GST rate and HSN code for Montair FX Tablet?

Montair FX Tablet is subject to 5% GST under HSN code 3004 as per Indian tax regulations for pharmaceutical products.

What is the schedule classification of Montair FX Tablet?

Montair FX Tablet is classified as a Schedule H medication, which means it requires a valid prescription from a registered medical practitioner for purchase.

What are some common brand variants of Montelukast 10mg in India?

Common brand variants of Montelukast 10mg in India may include Montair, Montek, Airlukast, and Montekast, among others available from various pharmaceutical manufacturers.

Selling Montair FX Tablet at your pharmacy?

Nesayo tracks your stock, flags near-expiry, and auto-orders from your distributor when you run low.

Start free →

This page is informational only. Pricing and availability vary by pharmacy, location, and time. Verify current MRP on the printed package before sale. Consult a registered physician or pharmacist for medical advice. Nesayo is not a medical device and does not provide clinical decision support.